X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (106) 106
index medicus (87) 87
oncology (86) 86
female (66) 66
middle aged (59) 59
male (58) 58
aged (54) 54
lung cancer (54) 54
respiratory system (50) 50
adult (43) 43
chemotherapy (43) 43
cancer (42) 42
lung neoplasms - pathology (39) 39
lung neoplasms - drug therapy (36) 36
carcinoma, non-small-cell lung - drug therapy (31) 31
mutation (28) 28
treatment outcome (28) 28
neoplasm staging (26) 26
carcinoma, non-small-cell lung - pathology (24) 24
lung neoplasms - genetics (24) 24
prognosis (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
care and treatment (22) 22
life sciences (22) 22
lung neoplasms - mortality (22) 22
aged, 80 and over (21) 21
tumors (21) 21
apoptosis (20) 20
carcinoma, non-small-cell lung - genetics (20) 20
lung cancer, non-small cell (20) 20
disease-free survival (19) 19
patients (19) 19
docetaxel (18) 18
hematology, oncology and palliative medicine (18) 18
immunotherapy (18) 18
metastasis (17) 17
carcinoma, non-small-cell lung - mortality (16) 16
expression (16) 16
prospective studies (16) 16
retrospective studies (16) 16
therapy (16) 16
adenocarcinoma (15) 15
nivolumab (15) 15
open-label (14) 14
survival (14) 14
lung neoplasms - metabolism (13) 13
lung neoplasms - therapy (13) 13
pulmonary/respiratory (13) 13
antineoplastic agents - therapeutic use (12) 12
follow-up studies (12) 12
gefitinib (12) 12
survival rate (12) 12
abridged index medicus (11) 11
biomarkers (11) 11
clinical trials (11) 11
gene (11) 11
nsclc (11) 11
risk factors (11) 11
surgery (11) 11
activation (10) 10
analysis (10) 10
animals (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
carcinoma, non-small-cell lung - metabolism (10) 10
cisplatin (10) 10
immunohistochemistry (10) 10
multicenter (10) 10
non-small cell lung carcinoma (10) 10
protein kinase inhibitors - therapeutic use (10) 10
trial (10) 10
adenocarcinoma - drug therapy (9) 9
adenocarcinoma - genetics (9) 9
carcinoma, non-small-cell lung - therapy (9) 9
cell biology (9) 9
classification (9) 9
disease progression (9) 9
gene expression regulation, neoplastic (9) 9
kaplan-meier estimate (9) 9
lung neoplasms - diagnosis (9) 9
proteins (9) 9
research (9) 9
adenocarcinoma - pathology (8) 8
beta-catenin (8) 8
cancer therapies (8) 8
carcinoma (8) 8
cell line, tumor (8) 8
egfr (8) 8
growth-factor receptor (8) 8
human health and pathology (8) 8
metastases (8) 8
mice (8) 8
mutations (8) 8
signal transduction (8) 8
young adult (8) 8
antibodies, monoclonal - therapeutic use (7) 7
carboplatin (7) 7
cohort studies (7) 7
dna methylation (7) 7
epidermal growth factor receptors (7) 7
gene expression (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 257 - 265
Journal Article
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 910 - 14
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10030, pp. 1837 - 1846
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1405 - 1414
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1415 - 1426
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 984 - 993
Summary Background BRAF mutations act as an oncogenic driver via the mitogen-activated protein kinase (MAPK) pathway in non-small cell lung cancer (NSCLC).... 
Hematology, Oncology and Palliative Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 21, pp. 2040 - 2051
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 9, pp. 992 - +
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 642 - 650
Summary Background Activating BRAFV600E (Val600Glu) mutations are found in about 1–2% of lung adenocarcinomas, which might provide an opportunity for targeted... 
Hematology, Oncology and Palliative Medicine
Journal Article